DOXY-SONE - goovetvn.com

  • vn
  • eg

DOXY-SONE

Lượt xem : 672

Treatment of respiratory tract infections. Rhinitis, tonsillitis, bronchopneumonia.

Contact

Product Information

Reg No.: GOV-121

Trade name: DOXY-SONE

Dosage form: Oral tablet

Composition: Each tablet contains:

Doxycycline hyclate: 20 mg

Excipients qs: 01 tablet

Indications

Treatment of respiratory tract infections in dogs and cats: rhinitis, tonsillitis, bronchopneumonia, respiratory diseases caused by Pasteurella spp, Bordetella bronchiseptica, Staphylococcus spp and Streptococcus spp. Treatment of Ehrlichia canis infections caused by arthropods in dogs and cats.

Treatment of CRD, rhinitis, nasal discharge, gastrointestinal infections, E.coli, Salmonella, arthritis due to infections in ornamental birds, pigeons, fighting cocks and ornamental chickens.

Dose and administration

Administer orally, should be given at feeding times.

- Dogs, cats: 1 tablet per 2 kg body weight per day, for 3-5 days.

- Poultry, ornamental birds, pigeons: 1 tablet per 1 kg body weight per day, for 3-5 days.

Contraindication

- Do not use in pregnant animals.

- Do not use in animals with known hypersensitivity to components of the product.

Withdrawal period: None

Storage: Keep it in a cool dry place, protected from direct sunlight. Temperature not exceeding 30oC.

FOR VETERINARY USE ONLY

 

Nhận tư vấn

Please free contact to us if you need any information more.

Full Name(*)
Trường bắt buộc

Phone
Invalid Input

Address
Invalid Input

Messages(*)
Trường bắt buộc

Submit

RELATED PRODUCTS

G-FEBENDAZOL

G-FEBENDAZOL

Contact
DOXY-SONE

DOXY-SONE

Contact
G-ENROCIN

G-ENROCIN

Contact
LEVAMISOL

LEVAMISOL

Contact

CONTACT US

Goovet Group Joint Stock Company

-------------------------------

Address: LOT CN5, Thuy Van Industrial Park, Thuy Van Commune, Viet Tri City, Phu Tho Province

Tax Code: 2600 973 967

Hotline: (0210)3 555 855 – 3 555 955

Whatsapp - +84975918882

Email: [email protected]

Website: https://goovetvn.com/

 

Follow Youtube Channel

FOLLOW US

 

Newsletter